Results 151 to 160 of about 43,423 (294)
Expert Treatment Considerations for Lower Face and Neck Rejuvenation
ABSTRACT Background The lower face and neck are essential to overall facial harmony and a balanced appearance. Although most nonsurgical treatments have focused on the upper and midface, a variety of minimally invasive options are now available for treating the lower face and neck that target different aesthetic concerns and provide welcome ...
Sabrina Fabi +6 more
wiley +1 more source
Acute esophageal tear in eosinophilic esophagitis
Föh, Bandik +3 more
openaire +2 more sources
ABSTRACT Aim Tegoprazan, a potassium‐competitive acid blocker, is an acid‐suppressing medication under review as a potential alternative treatment in cases of erosive esophagitis. This systematic review and meta‐analysis assesses the efficacy and tolerability of tegoprazan compared to proton pump inhibitors, the current standard of care. Methods Pubmed,
Youssef Diab +6 more
wiley +1 more source
The Esophageal Microbiome in Eosinophilic Esophagitis [PDF]
openaire +2 more sources
From Oral Candidiasis to Candidemia: A Review of Superficial to Invasive Progression
Recent and limited evidence indicates that oral candidiasis can disseminate Candida albicans throughout the body, leading to invasive candidiasis, such as candidemia, a life‐threatening infection. Considering antifungal resistance and global outbreaks of emergent non‐albicans Candida and related yeasts, murine models help understand dissemination ...
Julia Robledo Jerez +3 more
wiley +1 more source
A tailored non‐uniform PTV strategy (including PTVcrop and PTV_high/PTV_low) was used in SBRT for ultra‐central NSCLC to meet stringent OAR constraints. Notably, this SBRT strategy achieved favorable clinical outcomes, with an 84.6% 3‐year local control rate, a median PFS of 42.9 months. Additionally, treatment‐related toxicity was mild, with only 1.5%
Di Liu +11 more
wiley +1 more source
Abstract Background Short bowel syndrome (SBS) is a chronic condition requiring parenteral nutrition (PN) support and multidisciplinary management. However, disparities in access to care and standardized treatment pathways, in addition to economic burden, remain considerable for patients.
Deborah Kuk +7 more
wiley +1 more source
In patients with atherothrombotic disease on antithrombotic therapy, P‐CABs demonstrated a significantly superior protective effect against clinically significant upper GI haemorrhage compared to PPIs (aHR 0.22; p = 0.016). This real‐world study highlights P‐CABs as a more potent gastroprotective strategy for high‐risk populations requiring intensive ...
Min Joo Yoon +6 more
wiley +1 more source
Esophageal Lichen Planus: Highlighting Diagnostic Challenges and Therapeutic Limitations. [PDF]
Bahmani A, Kemmerly T, Yang BE.
europepmc +1 more source
Esophageal Atresia and Tracheo-Esophageal Fistula
W E, Ladd, O, Swenson
openaire +3 more sources

